ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

ALK’s new data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors: Denmark Monday, March 2, 2026, 18:00 Hrs [IST] ALK, a global sp ...

The Benedict Blythe Foundation has welcomes the government’s launch of a national consultation on new statutory guidance to improve allergy safety in schools.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best cheap biotech stocks to buy now. Halozyme Therapeutics, Inc. (NASDAQ:HALO) has received several bullish rating updates from analysts ...

For more than a decade, families, clinicians and coroners have warned that allergy safety in our schools is too often left to chance. During that ...

Carver debuts redesigned laboratory presses with enhanced touchscreen interface and automated pelletizing capabilities.

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with “solid” results and entered 2026 with positive momentum, driven by continued strength in its Biopharmaceutical and Diagn ...

Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.

Moby summary of Stevanato Group S.p.A.'s Q4 2025 earnings call ...

Life-saving allergy pens must be stocked by schools for the first time under new plans announced today. Life-saving allergy pens must be stocked by ...

Executive SummaryThe global pharmaceutical drug delivery sector operates as a central pillar within the broader life sciences industry. As treatment protocols shift from conventional dosing toward ...

These automation devices are also being introduced to logistics environments, as the marketplace grows to a projected $30 ...